Clinical Trials Logo
  1. Home
  2. Chronic Obstructive Pulmonary Disease
  3. NCT02315131

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Chronic Obstructive Pulmonary Disease (COPD Clinical Trial

Official title:
A 2-Stage, Single-Dose Study in Healthy Volunteers and COPD Patients With an Open Label Ipratropium Bromide Reference to Evaluate the Efficacy, Pharmacokinetics, and Safety Profile of Inhaled TV46017

Clinical Trial Summary

The primary objective of the study is to characterize the safety profile and duration of bronchodilation of a single dose of inhaled TV46017

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02315131
Study type Interventional
Source Teva Branded Pharmaceutical Products R&D, Inc.
Contact
Status Terminated
Phase Phase 1
Start date March 2015
Completion date August 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT04684836 - Comparative Effectiveness of Telemedicine in Primary Care
Active, not recruiting NCT04966637 - Identifying Early Chronic Obstructive Pulmonary Disease (COPD) Using Health Administrative Data
Recruiting NCT04195191 - Intervention to Improve the Adherence in Community Pharmacies N/A
Completed NCT02864342 - Adherence Study in COPD Patients Phase 4
Completed NCT03639220 - Photobiomodulation Therapy in Exercise Capacity Assessed by 6MST in Patients With COPD N/A